SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is gaining significant community attention as a perceived beneficiary of the European natural gas crisis, with investors citing its critical infrastructure and low-float structure as potential catalysts for a squeeze. Traders are actively debating the upside of both the stock and its warrants amid ongoing geopolitical instability, with many highlighting its perceived value compared to other high-volatility oil and gas plays.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors react to the company securing significant clinical and regulatory milestones, including marketing approval in Japan, while maintaining a robust cash position without the immediate need for dilution. Community discussion is heavily focused on upcoming U.S. trial readouts and the potential for a broader valuation correction as analysts continue to issue optimistic price targets.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as retail investors rally behind its long-term potential in AI infrastructure and 6G development, often discussing the stock as a resilient, multi-thematic play despite recent market volatility. Discussion is heavily driven by its strategic partnerships with industry heavyweights like Nvidia, contract wins in defense and optical networking, and persistent institutional accumulation that has fueled bullish sentiment among long-term holders.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market interest driven by growing anticipation surrounding a potential SpaceX IPO, which investors view as a broader validator for the satellite communications sector. The community is actively debating the company's long-term growth potential and execution roadmap while reacting to recent price volatility and institutional activity.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo Finance is attracting attention due to its strategic partnership with Franklin Templeton to tokenize traditional assets, fueling investor optimism about its role in bridging Wall Street with decentralized finance. While some in the community remain skeptical of recent price action, many actively discuss its long-term potential as a premier real-world asset (RWA) play.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a significant analyst upgrade to a $40 price target, fueling speculation about the company's long-term potential as a best-in-class acquisition target for Big Pharma. Investors are closely monitoring upcoming Phase 3 trial data, with the community actively debating whether the company will secure a buyout or continue as an independent entity.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

The DOG community is buzzing following rumors of a Coinbase listing, fueling excitement around its position as a primary memecoin within the Bitcoin Runes ecosystem. Supporters are highlighting its decentralized structure and fixed supply as key advantages over inflationary alternatives, with many actively accumulating in anticipation of a broader market shift.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

Market sentiment for SPY is currently gripped by extreme volatility and 'extreme fear' as participants debate the potential impact of intensifying conflict in the Middle East, with many traders closely monitoring energy supply disruptions and geopolitical escalations. While the community is sharply divided between those bracing for a deeper correction and those anticipating a potential relief rally, active discussions are focused on how these tensions and shifting macro narratives will influence short-term price action.

Invesco CurrencyShares Euro Trust - Units of fractional undivided beneficial interest

Invesco CurrencyShares Euro Trust

Invesco CurrencyShares Euro Trust is attracting significant attention as traders analyze the potential for European Central Bank policy adjustments amid fluctuating energy costs and shifting U.S. interest rate expectations. The community is heavily focused on technical patterns and macro catalysts, weighing the impacts of regional geopolitical tensions against broader forex volatility.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending as investors digest the strategic acquisition of StereoLabs, which consolidates lidar, camera, and AI perception software into a unified platform for the growing Physical AI market. While the stock faces broader market volatility, community discussion remains focused on the company's path to profitability, recent leadership commentary on future product releases, and its expanding footprint in defense, industrial automation, and smart infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026

ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 ATRA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds...

Law Offices of Howard G. Smith Encourages Atara Biotherapeutics, Inc. (ATRA) Shareholders To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchasedAtara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ:ATRA) securities...

Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the...

Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA

Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA Pomerantz Law Firm Announces the Filing of a Class Action Against Atara...

Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) investors concerning the Companys possible violations of...

Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights ATRA

The DJS Law Group reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission...

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) violations of...

Securities Fraud Investigation Into Atara Biotherapeutics, Inc. (ATRA) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz announces an investigation of Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ: ATRA) on behalf of investors concerning the Companys possible violations of...

INVESTOR ALERT: Securities Class Action Filed Against Atara Biotherapeutics, Inc. Investors Encouraged to Contact Kirby McInerney LLP

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Atara Biotherapeutics, Inc. (Atara or the Company) (NASDAQ:ATRA...

ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc.

ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc. ATRA Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Atara Biotherapeutics, Inc. PR Newswire...

$ATRA Q4 &#39;25 Earnings Results &amp; Recap

Atara Biotherapeutics anticipates its existing capital resources of $8.5M as of December 31, 2025, will be insufficient to fund planned operations for at least the next twelve months.

Stocktwits

Atara Biotherapeutics Inc

 Q4 '25 Earnings Results & Recap

Atara Biotherapeutics anticipates its existing capital resources of $8.5M as of December 31, 2025, will be insufficient to fund planned operations for at least the next twelve months.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Current Price	$4.59
Prev Close	$4.71
Open	$4.71
Dividend Yield	0.00%
50-Day Moving Average	$5.06
Beta	2.22
Avg. Volume	136,424.98
PE Ratio	1.57

52-Week High	$19.15
52-Week Low	$3.92
Market Capitalization	$37.54M
EPS (Annual)	$2.57
Price to Book	-0.87
Revenue Per Employee	$8.63M

ATRA
Atara Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ATRA News

ATRAAtara Biotherapeutics Inc